These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1434067)

  • 1. A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade.
    Yamashita K; Matsunaga Y; Taylor-Wiedeman J; Yamazaki S
    Jpn J Med Sci Biol; 1992 Apr; 45(2):49-58. PubMed ID: 1434067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of antibody to human parvovirus B19 in Singapore.
    Matsunaga Y; Goh KT; Utagawa E; Muroi N
    Epidemiol Infect; 1994 Dec; 113(3):537-40. PubMed ID: 7995362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Seroepidemiology of human parvovirus B19 using recombinant VP1 + VP2 particle antigen].
    Matsunaga Y; Takeda N; Yamazaki S; Kamata K; Kurosawa D
    Kansenshogaku Zasshi; 1995 Dec; 69(12):1371-5. PubMed ID: 8586889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroprevalence of human parvovirus B19 in children with fever and rash in the North of Tunisia].
    Bouafsoun A; Hannachi N; Smaoui H; Boubaker SH; Kazdaghli K; Laabidi D; Boukadida J; Kechrid A
    Bull Soc Pathol Exot; 2016 Aug; 109(3):165-71. PubMed ID: 27385036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human parvovirus B19 infection in blood donors.
    Tsujimura M; Matsushita K; Shiraki H; Sato H; Okochi K; Maeda Y
    Vox Sang; 1995; 69(3):206-12. PubMed ID: 8578732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy?
    Gay NJ; Hesketh LM; Cohen BJ; Rush M; Bates C; Morgan-Capner P; Miller E
    Commun Dis Rep CDR Rev; 1994 Aug; 4(9):R104-7. PubMed ID: 7522807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 antibodies in patients with haemophilia A.
    Peerlinck K; Goubau P; Reybrouck R; Desmyter J; Vermylen J
    Thromb Haemost; 1995 Mar; 73(3):555-6. PubMed ID: 7667846
    [No Abstract]   [Full Text] [Related]  

  • 8. [The frequency of human parvovirus B19 infections in Vojvodina].
    Milosević V; Jerant-Patić V; Hrnjaković-Cvjetković I; Vukmanović-Papuga M; Jelena RT; Kovacević G
    Med Pregl; 2007; 60(11-12):575-9. PubMed ID: 18666599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
    Nunoue T
    Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of epidemiology and fetal effects of human parvovirus B19 infection].
    Oka H
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jun; 45(6):533-9. PubMed ID: 8315312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays.
    Rice PS; Cohen BJ
    Epidemiol Infect; 1996 Jun; 116(3):331-8. PubMed ID: 8666078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
    Türk Dağı H; Ozdemir M; Baykan M; Baysal B
    Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parvovirus B19 infection: the general aspects and gestational problems].
    Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
    Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The seroprevalence of parvovirus B19 antibody in blood donors at the National Blood Transfusion Center in Kinshasa.
    Chabo Byaene A; Kabututu ZP; Abou Rayia DM; El-Sokkary MMA
    J Med Virol; 2020 Mar; 92(3):288-294. PubMed ID: 31646654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
    Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
    Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.
    Erdman DD; Usher MJ; Tsou C; Caul EO; Gary GW; Kajigaya S; Young NS; Anderson LJ
    J Med Virol; 1991 Oct; 35(2):110-5. PubMed ID: 1765775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil).
    Oliveira SA; Camacho LA; Pereira AC; Faillace TF; Setubal S; Nascimento JP
    Mem Inst Oswaldo Cruz; 2002 Oct; 97(7):965-70. PubMed ID: 12471422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to parvovirus B19 in selected groups of patients and healthy individuals.
    Schwarz TF; Hottenträger B; Roggendorf M
    Zentralbl Bakteriol; 1992 Feb; 276(3):437-42. PubMed ID: 1576413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).
    Brown KE; Hibbs JR; Gallinella G; Anderson SM; Lehman ED; McCarthy P; Young NS
    N Engl J Med; 1994 Apr; 330(17):1192-6. PubMed ID: 8139629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study by means of a new assay of the relationship between an outbreak of erythema infectiosum and non-immune hydrops fetalis caused by human parvovirus B19.
    Yaegashi N; Okamura K; Tsunoda A; Nakamura M; Sugamura K; Yajima A
    J Infect; 1995 Nov; 31(3):195-200. PubMed ID: 8586838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.